JP4454988B2 - Sustained release formulation - Google Patents

Sustained release formulation Download PDF

Info

Publication number
JP4454988B2
JP4454988B2 JP2003306897A JP2003306897A JP4454988B2 JP 4454988 B2 JP4454988 B2 JP 4454988B2 JP 2003306897 A JP2003306897 A JP 2003306897A JP 2003306897 A JP2003306897 A JP 2003306897A JP 4454988 B2 JP4454988 B2 JP 4454988B2
Authority
JP
Japan
Prior art keywords
fatty acid
volatile
liquid
container
acid triglyceride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003306897A
Other languages
Japanese (ja)
Other versions
JP2005075762A (en
Inventor
孝一 岡原
清 亀井
秀直 斎藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rengo Co Ltd
Original Assignee
Rengo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rengo Co Ltd filed Critical Rengo Co Ltd
Priority to JP2003306897A priority Critical patent/JP4454988B2/en
Publication of JP2005075762A publication Critical patent/JP2005075762A/en
Application granted granted Critical
Publication of JP4454988B2 publication Critical patent/JP4454988B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

この発明は、揮散性薬剤を徐々に放出する製剤に関する。   The present invention relates to a preparation that gradually releases a volatile drug.

これまでに、揮散性薬剤を徐々に放出する技術として、例えば、上記揮散性薬剤と均一に混合可能である樹脂を混練して上記揮散性薬剤を徐々に放出する徐放剤が特許文献1に、多孔性包装基材の孔の一部を狭窄化したものが特許文献2に示されている。また、常温でペースト状や固形状を呈する脂肪酸高級アルコールエステルやパラフィン、脂肪酸グリセリンエステルを用いたものが特許文献3に示されている。   So far, as a technique for gradually releasing a volatile drug, for example, Patent Document 1 discloses a sustained release agent that kneads a resin that can be uniformly mixed with the volatile drug and gradually releases the volatile drug. Patent Document 2 discloses a narrowed part of the pores of the porous packaging substrate. Patent Document 3 discloses a fatty acid higher alcohol ester, paraffin, or fatty acid glycerin ester that is pasty or solid at room temperature.

特開2000ー186002号公報JP 2000-186002 A WO95/12981号公報WO95 / 12981 特許第2796589号公報Japanese Patent No. 2796589

しかしながら、特許文献1に記載されている上記揮散性薬剤の揮散を抑制する樹脂としては、ロジン系樹脂、セラック系樹脂、エチレン−酢酸ビニル共重合体等があげられているが、これらの樹脂は、遊離有機酸やアルコールのカルボニル基や水酸基等を有しているため、上記揮散性薬剤そのものと反応してしまい、これらの樹脂又は上記揮散性薬剤を変色させたり、臭いを変化させたりする場合があった。さらに、ロジンエステル樹脂は、それが含有する不純物の酸化によっても変色する問題があった。   However, examples of resins that suppress the volatilization of the volatile chemicals described in Patent Document 1 include rosin resins, shellac resins, ethylene-vinyl acetate copolymers, and the like. In the case of having a carbonyl group or a hydroxyl group of a free organic acid or alcohol, it reacts with the volatile chemical itself, and these resins or the volatile chemical are discolored or the odor is changed. was there. Furthermore, the rosin ester resin has a problem of discoloration due to oxidation of impurities contained therein.

また、特許文献2に記載の方法では、包装材の内容物が液体であったり、液体を担体に含浸させたりした場合に、ピンホール等により容易に容器から染み出してしまい、上記揮散性薬剤の揮散制御ができなくなる場合があった。   Further, in the method described in Patent Document 2, when the contents of the packaging material are liquid or when the liquid is impregnated into the carrier, the volatile chemical is easily oozed out of the container by a pinhole or the like. In some cases, volatilization control could not be performed.

さらに、特許文献3で用いられている、常温でペースト状や固形状を呈する脂肪酸高級アルコールエステル、パラフィンは、上記揮散性薬剤に対する揮散抑制効果が乏しく、好ましくなかった。同じく用いられている脂肪酸グリセリンエステルは、構成する脂肪酸の炭素数しだいでペースト状や固形状になると、上記揮散性薬剤との親和性が低くなり、上記揮散性薬剤の効率のよい揮散抑制ができない場合があった。さらにまた、脂肪酸グリセリンエステルが、ジグリセリド又はモノグリセリドの場合では、分子内に水酸基を有しているため、上記揮散性薬剤そのものと反応する場合があった。   Furthermore, the fatty acid higher alcohol ester and paraffin which are used in Patent Document 3 and exhibit a paste or solid form at normal temperature are not preferable because they have a poor volatilization suppressing effect on the above volatilizing agents. When the fatty acid glycerin ester used in the same way becomes pasty or solid depending on the number of carbon atoms of the fatty acid constituting it, the affinity with the volatile agent is lowered, and the volatile agent cannot efficiently suppress volatilization. There was a case. Furthermore, when the fatty acid glycerin ester is a diglyceride or a monoglyceride, the fatty acid glycerin ester may react with the volatile drug itself because it has a hydroxyl group in the molecule.

そこでこの発明は、揮散性薬剤を反応させることなく、揮散性薬剤との親和性が高く、揮散性薬剤の効率のよい揮散抑制が行える徐放性製剤を製造することを目的とする。   Therefore, an object of the present invention is to produce a sustained-release preparation that has a high affinity with a volatile drug and can efficiently suppress the volatile drug without reacting the volatile drug.

この発明は、揮散性薬剤と、下記化学式(1)で示される常温で液体の脂肪酸トリグリセリドと、常温で固体の疎水性物質とを混練して、混練物を作成し、この混練物を液体不透過性の容器に充填した徐放性製剤によって上記の問題を解決したのである。   This invention kneads a volatile drug, a fatty acid triglyceride that is liquid at normal temperature represented by the following chemical formula (1), and a hydrophobic substance that is solid at normal temperature to create a kneaded product. The above problem was solved by a sustained-release preparation filled in a permeable container.

Figure 0004454988
Figure 0004454988

上記化学式(1)で示される常温で液体の脂肪酸トリグリセリドは、揮散性薬剤との親和性がよく、効率よく揮散性薬剤の揮散抑制ができる。また、常温で固体の疎水性物質と混練することにより、混練物を固形物として扱うことができ、染み出しを起きにくくすることができる。   The fatty acid triglyceride that is liquid at room temperature represented by the chemical formula (1) has good affinity with the volatile drug, and can efficiently suppress the volatilization of the volatile drug. Further, by kneading with a solid hydrophobic substance at room temperature, the kneaded material can be handled as a solid material, and bleeding can be made difficult to occur.

この発明にかかる徐放性製剤は、変質を起こす心配がなく、揮散性薬剤との親和性がよい液体の脂肪酸トリグリセリドを用いることで、反応を起こさせず、保管中における結露を防止し、効率よく揮散を抑制し、有効期間を持続させることができる。さらに、固体又はペースト状にしたものを液体不透過性の容器に充填するため、染み出しが起こりにくい。   The sustained-release preparation according to the present invention has no fear of degeneration, uses liquid fatty acid triglycerides with good affinity with volatile drugs, does not cause reaction, prevents condensation during storage, and is efficient Volatilization is well suppressed and the effective period can be maintained. Furthermore, since the liquid or impervious container is filled with the solid or pasty material, exudation hardly occurs.

以下、この発明を詳細に説明する。
この発明は、揮散性薬剤と、脂肪酸部分がC2〜C12の脂肪酸である常温で液体の脂肪酸トリグリセリドと、常温で固体の疎水性物質とを混練して、混練物を作成し、この混練物を液体不透過性の容器に充填した徐放性製剤である。
Hereinafter, the present invention will be described in detail.
This invention kneads a volatilizing agent, a fatty acid triglyceride having a fatty acid portion of C2 to C12 fatty acid at room temperature and a solid hydrophobic substance at room temperature to prepare a kneaded product. This is a sustained-release preparation filled in a liquid-impermeable container.

上記の揮散性薬剤とは、常温で固体又は液体でありながら、常温で揮発することができ、気体状態で何らかの効果を奏するものをいう。例えば、殺菌剤、除菌剤、芳香剤、害虫忌避剤、殺虫剤、防腐剤、防カビ剤などである。上記揮散性薬剤の具体例としては、ピレスロイド、ハッカ油、ターピネオール、パラジクロロベンゼン、ナフタリン、樟脳等の防虫・忌避剤、ピネン、リモネン、カンフェン、テルビノーレン、リナロール、ゲラニオール、シトロネロール、シトラール、ベンズアルデヒド、カルボン、メントン、クマリン、アニソール、チモール、オイゲノール、アネトール、桂皮酸、フェニル酢酸、ヒドロ桂皮酸、酢酸エチル、酢酸ゲラニル、プロピオン酸イソアミル、ローズオキサイド、オキサイドケトン、シネオール、インドール、スカトール、メチルキノリン、ムスク、シベット、カストリウム、アンバーグリス、レモン油、バラ油、白檀油、ラベンダー油、ジャスミン油等の香料、イソチオシアン酸アリル、オクチルアルデヒド、ブロムシンナミルアルデヒド等の抗菌・防カビ剤、ヒバ油、ヒノキ油、キリ油、キンモクセイ抽出油、ツバキ油、ユーカリ油、シソ油、ワサビ抽出油、マスタード油、月桃油等の精油・消臭剤等が挙げられる。   Said volatile chemical | medical agent means the thing which can volatilize at normal temperature and has a certain effect in a gaseous state, although it is solid or liquid at normal temperature. For example, bactericides, disinfectants, fragrances, pest repellents, insecticides, antiseptics, fungicides and the like. Specific examples of the volatile agent include pyrethroid, mint oil, terpineol, paradichlorobenzene, naphthalene, camphor and other insect repellents and repellents, pinene, limonene, camphene, terbinolene, linalool, geraniol, citronellol, citral, benzaldehyde, carvone, Menthone, coumarin, anisole, thymol, eugenol, anethole, cinnamic acid, phenylacetic acid, hydrocinnamic acid, ethyl acetate, geranyl acetate, isoamyl propionate, rose oxide, oxide ketone, cineole, indole, skatole, methylquinoline, musk, civet , Perfumes such as castrium, ambergris, lemon oil, rose oil, sandalwood oil, lavender oil, jasmine oil, allyl isothiocyanate, octylaldehyde, bromcinami Antibacterial and antifungal agents such as aldehydes, Hiba oil, Hinoki oil, Kiri oil, Buttercup oil extract, Camellia oil, Eucalyptus oil, Perilla oil, Wasabi extract oil, Mustard oil, Moon peach oil, etc. Can be mentioned.

上記常温で液体の脂肪酸トリグリセリドとは、一当量のグリセリンと三当量の脂肪酸からなるエステルのうち、下記化学式(1)で示される化合物をいう。ここで、p,q,rは1〜11の自然数である。すなわち、それぞれのエステル部を構成する脂肪酸の炭素数は2〜12の自然数である。この数値の範囲内であれば、それぞれの数値が異なる脂肪族トリグリセリドが混合していてもよい。この化合物を混練することにより、上記揮散性薬剤の蒸気圧を低下させ、揮散を抑制することが出来る。   The fatty acid triglyceride that is liquid at normal temperature refers to a compound represented by the following chemical formula (1) among esters composed of one equivalent of glycerin and three equivalents of fatty acid. Here, p, q, and r are natural numbers from 1 to 11. That is, the carbon number of the fatty acid which comprises each ester part is a natural number of 2-12. If it is in the range of this numerical value, the aliphatic triglyceride from which each numerical value differs may be mixed. By kneading this compound, the vapor pressure of the volatile chemical can be reduced, and volatilization can be suppressed.

Figure 0004454988
Figure 0004454988

これに対して、脂肪酸部分がC13以上の脂肪酸であり常温で固体である脂肪酸トリグリセリドでは、上記揮散性薬剤との親和性が低く、揮散抑制効果が小さいため、混練する意味に乏しい。   On the other hand, fatty acid triglycerides whose fatty acid part is a fatty acid of C13 or higher and are solid at normal temperature have low affinity with the above volatile chemicals and have a small volatilization suppressing effect, and therefore, the meaning of kneading is poor.

また、脂肪酸モノグリセリドや脂肪酸ジグリセリドでは、分子内に水酸基が残っており、この水酸基が上記揮散性薬剤と反応して変色等を起こしてしまうおそれがあるため、好ましくない。   In addition, fatty acid monoglyceride and fatty acid diglyceride are not preferable because a hydroxyl group remains in the molecule and the hydroxyl group may react with the volatile agent to cause discoloration.

上記の常温で固体の疎水性物質とは、上記揮散性薬剤と上記の常温で液体の脂肪酸トリグリセリドとを混練して、固化させ、液の染み出しを抑えるものである。この疎水性物質として用いることができる物質は、石油ワックス、ロジンエステル樹脂等のロジン系樹脂、セラック系樹脂、エチレン−酢酸ビニル共重合体、ポリアミド、シュガーエステル、遊離脂肪酸やアルコール基を含有する天然ワックス、高級脂肪酸、高級アルコール、さらに、ポリエステル、ポリスチレン、ポリオレフィン、アクリル系樹脂等の合成高分子ポリマー等が挙げられる。   The above-mentioned hydrophobic substance that is solid at room temperature is a substance that kneads the volatile chemical and the fatty acid triglyceride that is liquid at room temperature to solidify the liquid and suppress the seepage of the liquid. Substances that can be used as the hydrophobic substance include petroleum wax, rosin resin such as rosin ester resin, shellac resin, ethylene-vinyl acetate copolymer, polyamide, sugar ester, natural fatty acid containing alcohol group Examples thereof include waxes, higher fatty acids, higher alcohols, and synthetic polymer polymers such as polyesters, polystyrenes, polyolefins, and acrylic resins.

ただし、上記揮散性薬剤が不安定な物質である場合には、上記疎水性物質として、石油ワックスを使うことが特に望ましい。上記したもののうち、ロジン系樹脂、セラック系樹脂、エチレン−酢酸ビニル共重合体、ポリアミド等は、遊離有機酸やアルコールによるカルボニル基や水酸基等を含有しているために、これらと上記揮散性薬剤とが反応することにより、変色したり、臭いを変化させたりする可能性がある。また、天然ワックス、高級脂肪酸、高級アルコール、シュガーエステル等も、同様に上記揮散性薬剤を反応させてしまう可能性がある。さらに、上記合成高分子ポリマーでは、軟化点が高温であるために、混練しようとして上記揮散性薬剤が熱分解したり、粘度が高すぎて最終的に上記容器に充填できなくなったりする可能性がある。   However, when the volatile chemical is an unstable substance, it is particularly desirable to use petroleum wax as the hydrophobic substance. Of the above, rosin resins, shellac resins, ethylene-vinyl acetate copolymers, polyamides and the like contain carbonyl groups or hydroxyl groups by free organic acids or alcohols, so these and the above volatile chemicals. May cause discoloration or change in odor. Natural waxes, higher fatty acids, higher alcohols, sugar esters, and the like may similarly react with the volatile chemicals. Furthermore, in the synthetic polymer, since the softening point is high, the volatile chemical may be thermally decomposed when trying to knead, or the viscosity may be too high to finally fill the container. is there.

上記揮散性薬剤と上記脂肪酸トリグリセリドとを混練する際の混合比率は、上記混練物の調製時における上記脂肪酸トリグリセリドの混合重量比率が、上記の揮散性薬剤に対して0.1〜10倍の割合であることが望ましく、0.25〜5倍であればより望ましい。この混合重量比率が0.1倍未満であると、上記揮散性薬剤に対する揮散抑制効果がほとんど発揮されずに、上記揮散性薬剤が制限なく揮散してしまい、効果の持続が期待できない。また、混練した後の混練物を充填した容器が、上記揮散性薬剤によって結露する場合もある。一方、上記の混合重量比率が10倍を超えると、上記揮散性薬剤の揮散を抑制する効果はあるが、上記揮散性薬剤の揮散による減少に伴って揮散を抑制する効果が高くなりすぎてしまい、上記揮散性薬剤を有効な量だけ揮散させることが難しくなる場合がある。また、量が増えすぎて、製品である上記徐放性製剤のサイズが必要以上に大きくなってしまうことがある。また、上記揮散性薬剤と上記脂肪酸トリグリセリドとの合計に対する上記疎水性物質の混合重量比率は、特に限定されないが、0.05〜5倍の割合で混合し固化するように混合することが望ましい。0.05倍未満であると混練物がペースト状になりにくく、5倍を超えると製品は固形状となるが、サイズが必要以上に大きくなってしまうことがある。   The mixing ratio when kneading the volatile drug and the fatty acid triglyceride is such that the mixing weight ratio of the fatty acid triglyceride during the preparation of the kneaded product is 0.1 to 10 times the volatile drug. It is desirable that it is 0.25 to 5 times. If the mixing weight ratio is less than 0.1 times, the volatilization suppressing effect on the volatile drug is hardly exhibited, and the volatile drug is volatilized without restriction, and the effect cannot be expected to continue. Moreover, the container filled with the kneaded material after kneading may be condensed by the volatile chemical. On the other hand, when the mixing weight ratio exceeds 10 times, there is an effect of suppressing the volatilization of the volatile drug, but the effect of suppressing the volatility becomes too high with a decrease due to the volatilization of the volatile drug. In some cases, it is difficult to volatilize the volatile drug by an effective amount. Moreover, the amount may increase too much, and the size of the sustained-release preparation as a product may become larger than necessary. Moreover, the mixing weight ratio of the hydrophobic substance with respect to the total of the volatile drug and the fatty acid triglyceride is not particularly limited, but it is desirable to mix the mixture so as to be mixed and solidified in a ratio of 0.05 to 5 times. If it is less than 0.05 times, the kneaded product is difficult to form a paste, and if it exceeds 5 times, the product becomes solid, but the size may become larger than necessary.

このような上記揮散性薬剤と、上記の液体の脂肪酸トリグリセリドと、上記の疎水性物質とを混練して、混練物を作成する。なお混練とは、高粘度の混合物を、強いせん断力を用いて均一に混合・分散することをいう。混練する方法としては、一般的な混練方法を用いてよく、ミキサー、ニーダー等を用いる方法がある。ただし、上記揮散性薬剤が分解するような高温条件下での混練は、上記揮散性薬剤を変性させるおそれがあり、また、混練時に過剰に蒸発させるおそれもあるので望ましくない。   Such a volatile chemical, the liquid fatty acid triglyceride and the hydrophobic substance are kneaded to prepare a kneaded product. The kneading means that a highly viscous mixture is uniformly mixed and dispersed using a strong shearing force. As a kneading method, a general kneading method may be used, and there is a method using a mixer, a kneader or the like. However, kneading under a high temperature condition where the volatile chemical is decomposed is not desirable because the volatile chemical may be denatured and excessively evaporated during the kneading.

また、上記混練物にはこれらの他に、上記揮散性薬剤を安定化させる安定化剤として、酸化防止剤や光安定化剤等を添加してもよい。この酸化防止剤としては、例えば、ジブチルヒドロキシトルエン、ジブチルヒドロキシアニソール等が挙げられる。また、この光安定化剤としては例えば、2−ヒドロキシ−4−メトキシベンゾフェノン、2−(2’−ヒドロキシ−5’−メチルフェニル)ベンゾトリアゾール等が挙げられる。   Moreover, you may add antioxidant, a light stabilizer, etc. to the said kneaded material other than these as a stabilizer which stabilizes the said volatile chemical | medical agent. Examples of the antioxidant include dibutylhydroxytoluene and dibutylhydroxyanisole. Examples of the light stabilizer include 2-hydroxy-4-methoxybenzophenone and 2- (2'-hydroxy-5'-methylphenyl) benzotriazole.

上記の混練物を液体不透過性の容器に充填して、上記徐放性製剤が得られる。液体透過性であると、内容物が保管中もしくは使用中に漏れ出てしまい、揮散制御できなくなる可能性がある。また、揮散性薬剤を揮散させるために、上記容器の一部又は全部が気体透過性を有することが望ましい。液体不透過性かつ気体透過性を有する材質として、例えば、ポリエチレン、ポリプロピレン、ポリスチレン、ポリエチレンテレフタレート等が挙げられる。   The kneaded product is filled in a liquid-impermeable container to obtain the sustained-release preparation. If it is liquid permeable, the contents may leak during storage or use, and volatilization control may not be possible. Moreover, in order to volatilize a volatile chemical | medical agent, it is desirable for a part or all of the said container to have gas permeability. Examples of materials that are liquid impermeable and gas permeable include polyethylene, polypropylene, polystyrene, and polyethylene terephthalate.

以下、実施例によりこの発明をより具体的に説明する。   Hereinafter, the present invention will be described more specifically with reference to examples.

〔シネオールの揮散抑制効果と安定性〕
(実験例1)
[揮散濃度測定]
50mlの抽出ビン(マルエム社製)に、シネオール(小川香料(株)製)2.0gと、液体脂肪酸トリグリセリド(花王(株)製:ココナードML 含有脂肪酸炭素数:8、10、12)8.0gと、石油ワックス(日本精鑞(株)社製:HNP−9)2.0gを入れて密閉し、85℃で加熱混練して、相溶させた後、室温(約25℃)に放置した。
5日後、抽出ビン内の空間のシネオール濃度をガスクロマトグラフィー(ヒューレットパッカード社製:HP6890)により測定した。試験数はN=2で行い、得られた値の平均値を表1に示す。
[Cineol volatilization suppression effect and stability]
(Experimental example 1)
[Volatilization concentration measurement]
In a 50 ml extraction bottle (manufactured by Maruemu Co., Ltd.), 2.0 g of cineol (manufactured by Ogawa Fragrance Co., Ltd.) and liquid fatty acid triglyceride (manufactured by Kao Corp .: Coconut ML containing carbon number of fatty acids: 8, 10, 12) 0 g and 2.0 g of petroleum wax (manufactured by Nippon Seiki Co., Ltd .: HNP-9) are sealed, heat-kneaded at 85 ° C., dissolved, and left at room temperature (about 25 ° C.). did.
After 5 days, the cineol concentration in the space in the extraction bottle was measured by gas chromatography (Hewlett Packard, HP 6890). The number of tests was N = 2, and the average value obtained is shown in Table 1.

[臭い及び色の変化測定]
50ml抽出ビン(上記に同じ)に、シネオール2.0gと液体脂肪酸トリグリセリド(上記に同じ)8.0gを入れて密閉し、ウォーターバスで85℃に加熱混練して相溶させた後、袋状の容器に充填した。この容器の材質は、延伸ポリプロピレン(東洋紡(株)製:厚さ20μm)にポリエチレンラミネートを施した、厚み70μmの積層体とした。この容器を、密閉性のあるアルミ袋に入れて、60℃の環境で1ヶ月放置した。1ヶ月後の上記容器中にシネオールの臭いがするかどうか、また、色の変化があるかどうかを、嗅覚と視覚で確認した。その結果を表1に示す。なお、臭いが変化しないとは、シネオールの臭いそのままであることをいい、臭い、色共に、変化が感じられない場合を○、変化が感じられた場合を×とした。
[Measurement of odor and color change]
In a 50 ml extraction bottle (same as above), 2.0 g of cineol and 8.0 g of liquid fatty acid triglyceride (same as above) are sealed, heat-kneaded in a water bath at 85 ° C. The container was filled. The material of the container was a laminate having a thickness of 70 μm obtained by applying polyethylene laminate to stretched polypropylene (manufactured by Toyobo Co., Ltd .: thickness 20 μm). This container was put in an airtight aluminum bag and left in a 60 ° C. environment for one month. After one month, whether the sineol smelled in the container or whether there was a color change was confirmed by smell and vision. The results are shown in Table 1. Note that “the odor does not change” means that the odor of cineole remains as it is. The case where no change in both the odor and the color is felt is indicated as “◯”, and the case where a change is felt is indicated as “X”.

(実験例2)
実験例1において、液体脂肪酸トリグリセリド(花王(株)製:ココナードML 含有脂肪酸炭素数:8、10、12)の代わりに、脂肪酸トリグリセリド(和光純薬工業(株)製:トリアセチン 含有脂肪酸炭素数2)を用いた以外は、実験例1と同様にして、上記容器内のシネオール濃度及び臭いと色の変化を測定した。その結果を表1に示す。
(Experimental example 2)
In Experimental Example 1, instead of liquid fatty acid triglyceride (manufactured by Kao Corporation: Coconut ML-containing fatty acid carbon number: 8, 10, 12), fatty acid triglyceride (manufactured by Wako Pure Chemical Industries, Ltd .: triacetin-containing fatty acid carbon number 2) ) Was used in the same manner as in Experimental Example 1 to measure changes in cineol concentration, odor, and color in the container. The results are shown in Table 1.

(比較例1)
実験例1において、液体脂肪酸トリグリセリドを混練の際に入れずに、それ以外は実験例1と同様にして、上記容器内のシネオール濃度及び臭いと色の変化を測定した。その結果を表1に示す。
(Comparative Example 1)
In Experimental Example 1, liquid fatty acid triglyceride was not added at the time of kneading, and the changes in cineol concentration, odor, and color in the container were measured in the same manner as in Experimental Example 1 except that. The results are shown in Table 1.

(比較例2)
実験例1において、液体脂肪酸トリグリセリド(花王(株)製:ココナードML含有脂肪酸炭素数:8、10、12)の代わりに、ロジンエステル(荒川化学工業(株)製:A−18)を用いた以外は実験例1と同様にして、容器内のシネオール濃度及び臭いと色の変化を測定した。その結果を表1に示す。
(Comparative Example 2)
In Experimental Example 1, rosin ester (manufactured by Arakawa Chemical Industries, Ltd .: A-18) was used instead of liquid fatty acid triglyceride (manufactured by Kao Corporation: Coconut ML-containing fatty acid carbon number: 8, 10, 12). Except for the above, in the same manner as in Experimental Example 1, the cineol concentration, odor and color change in the container were measured. The results are shown in Table 1.

(比較例3)
実験例1において、液体脂肪酸トリグリセリド(花王(株)製:ココナードML含有脂肪酸炭素数:8、10、12)の代わりに、固体脂肪酸トリグリセリド(関東化学(株)製:トリステアリン 含有脂肪酸炭素数:18)を用いた以外は実験例1と同様にして、容器内のシネオール濃度及び臭いと色の変化を測定した。その結果を表1に示す。
(Comparative Example 3)
In Experimental Example 1, instead of liquid fatty acid triglyceride (manufactured by Kao Corporation: Coconut ML-containing fatty acid carbon number: 8, 10, 12), solid fatty acid triglyceride (manufactured by Kanto Chemical Co., Ltd .: Tristearin-containing fatty acid carbon number: Except for using 18), the cineol concentration, odor, and color change in the container were measured in the same manner as in Experimental Example 1. The results are shown in Table 1.

Figure 0004454988
Figure 0004454988

(結果)
液体の脂肪酸トリグリセリドを用いると、何も加えなかったときよりもシネオールの濃度は1000ppm以上低くなっており、また固体の脂肪酸トリグリセリドを用いるよりもさらに低くなっていた。このようにシネオールの濃度が低く抑えられていることから、揮散を抑制する効果が十分に現れていることがわかった。また、ロジンエステルを用いたときのような臭いや色の変化も無く、安定していた。
(result)
When liquid fatty acid triglycerides were used, the cineol concentration was 1000 ppm or more lower than when nothing was added, and even lower than when using solid fatty acid triglycerides. Thus, it was found that the effect of suppressing volatilization was sufficiently exhibited since the concentration of cineole was kept low. Moreover, there was no change in odor and color as in the case of using rosin ester, and it was stable.

〔イソチオシアン酸アリルの揮散抑制効果と安定性〕
(実験例3)
[揮散濃度測定]
50mlの抽出ビン(マルエム社製)に、イソチオシアン酸アリル(日本テルペン(株)製以下、「AIT」という。)5.0gと、液体脂肪酸トリグリセリド(花王(株)製:ココナードML 含有脂肪酸炭素数:8、10、12)2.3gと、石油ワックス(日本精鑞(株)社製:HNP−9)0.8gを入れて密閉し、85℃で加熱混練して、相溶させた後、室温(約25℃)に放置した。
5日後、抽出ビン内の空間のAIT濃度をガスクロマトグラフィー(ヒュ−レットパッカード社製:HP6890)により測定した。試験数はN=2で行い、得られた値の平均値を表2に示す。
[Efficacy and stability of allyl isothiocyanate]
(Experimental example 3)
[Volatilization concentration measurement]
In a 50 ml extraction bottle (manufactured by Maruemu Co., Ltd.), 5.0 g of allyl isothiocyanate (manufactured by Nippon Terpene Co., Ltd., hereinafter referred to as “AIT”) and liquid fatty acid triglyceride (manufactured by Kao Co., Ltd .: Coconut ML containing fatty acid carbon number : 8, 10, 12) After 2.3 g of petroleum wax (manufactured by Nippon Seisaku Co., Ltd .: HNP-9) was sealed, sealed, heated and kneaded at 85 ° C., and dissolved. And left at room temperature (about 25 ° C.).
After 5 days, the AIT concentration in the space in the extraction bottle was measured by gas chromatography (Hulet Packard: HP6890). The number of tests was N = 2, and the average value obtained is shown in Table 2.

[臭い及び色の変化測定]
50ml抽出ビン(上記に同じ)に、AIT5.0gと液体脂肪酸トリグリセリド(上記に同じ)2.3gを入れて密閉し、ウォーターバスで85℃に加熱混練して相溶させた後、袋状の容器に充填した。この容器の材質は、延伸ポリプロピレン(東洋紡(株)製:厚さ20μm)にポリエチレンラミネートを施した、厚み70μmの積層体とした。この容器を、密閉性のあるアルミ袋に入れて、60℃の環境で1ヶ月放置した。1ヶ月後の上記容器中にAITの臭いがするかどうか、また、色の変化があるかどうかを、嗅覚と視覚で確認した。その結果を表2に示す。なお、臭いが変化しないとは、AITの臭いそのままであることをいい、臭い、色共に、変化が感じられない場合を○、変化が感じられた場合を×とした。
[Measurement of odor and color change]
In a 50 ml extraction bottle (same as above), 5.0 g of AIT and 2.3 g of liquid fatty acid triglyceride (same as above) are sealed and heat-kneaded in a water bath at 85 ° C. to dissolve them. The container was filled. The material of the container was a laminate having a thickness of 70 μm obtained by applying polyethylene laminate to stretched polypropylene (manufactured by Toyobo Co., Ltd .: thickness 20 μm). This container was put in an airtight aluminum bag and left in a 60 ° C. environment for one month. After one month, whether or not there was an AIT odor in the container and whether there was a color change was confirmed by smell and vision. The results are shown in Table 2. In addition, the odor does not change means that the odor of the AIT remains as it is. A case where no change in both the odor and the color is felt is indicated as ◯, and a case where a change is felt is indicated as x.

(実験例4)
実験例3において、液体脂肪酸トリグリセリド(花王(株)製:ココナードML 含有脂肪酸炭素数:8、10、12)の代わりに、脂肪酸トリグリセリド(和光純薬工業(株)製:トリアセチン 含有脂肪酸炭素数:2)を用いた以外は実験例3と同様にして、上記容器内のAIT濃度及び臭いと色の変化を測定した。その結果を表2に示す。
(Experimental example 4)
In Experimental Example 3, instead of liquid fatty acid triglyceride (Kao Co., Ltd .: Coconut ML-containing fatty acid carbon number: 8, 10, 12), fatty acid triglyceride (Wako Pure Chemical Industries, Ltd .: Triacetin-containing fatty acid carbon number: The changes in AIT concentration, odor, and color in the container were measured in the same manner as in Experimental Example 3 except that 2) was used. The results are shown in Table 2.

(比較例4)
実験例3において、液体脂肪酸トリグリセリドを混練の際に入れずに、それ以外は実験例3と同様にして、上記容器内のAIT濃度及び臭いと色の変化を測定した。その結果を表2に示す。
(Comparative Example 4)
In Experimental Example 3, the liquid fatty acid triglyceride was not added at the time of kneading, and the changes in AIT concentration, odor, and color in the container were measured in the same manner as in Experimental Example 3 except that. The results are shown in Table 2.

(比較例5)
実験例3において、液体脂肪酸トリグリセリド(花王(株)製:ココナードML 含有脂肪酸炭素数:8、10、12)の代わりに、ロジンエステル(荒川化学工業(株)製:A−18)を用いた以外は実験例3と同様にして、上記容器内のAIT濃度及び臭いと色の変化を測定した。その結果を表2に示す。
(Comparative Example 5)
In Experimental Example 3, rosin ester (manufactured by Arakawa Chemical Industries, Ltd .: A-18) was used instead of liquid fatty acid triglyceride (manufactured by Kao Corporation: Coconut ML-containing fatty acid carbon number: 8, 10, 12). Except for the above, the AIT concentration, odor, and color change in the container were measured in the same manner as in Experimental Example 3. The results are shown in Table 2.

(比較例6)
実験例3において、液体脂肪酸トリグリセリド(花王(株)製:ココナードML含有脂肪酸炭素数:8、10、12)の代わりに、固体脂肪酸トリグリセリド(和光純薬工業(株)製:トリステアリン 含有脂肪酸炭素数:18)を用いた以外は実験例3と同様にして、上記容器内のAIT濃度及び臭いと色の変化を測定した。その結果を表2に示す。
(Comparative Example 6)
In Experimental Example 3, instead of liquid fatty acid triglyceride (manufactured by Kao Corporation: Coconut ML-containing fatty acid carbon number: 8, 10, 12), solid fatty acid triglyceride (manufactured by Wako Pure Chemical Industries, Ltd .: Tristearin-containing fatty acid carbon) The change in AIT concentration, odor, and color in the container was measured in the same manner as in Experimental Example 3 except that the number: 18) was used. The results are shown in Table 2.

(比較例7)
実験例3において、液体脂肪酸トリグリセリド(花王(株)製:ココナードML含有脂肪酸炭素数:8、10、12)の代わりに、グリセリン(和光純薬工業(株)製: 含有脂肪酸炭素数:0)を用いた以外は実験例3と同様にして、上記容器内のAIT濃度及び臭いと色の変化を測定した。その結果を表2に示す。
(Comparative Example 7)
In Experimental Example 3, glycerin (manufactured by Wako Pure Chemical Industries, Ltd .: carbon number of contained fatty acid: 0) instead of liquid fatty acid triglyceride (manufactured by Kao Corporation: coconut ML-containing fatty acid carbon number: 8, 10, 12) In the same manner as in Experimental Example 3 except that was used, changes in the AIT concentration, odor, and color in the container were measured. The results are shown in Table 2.

Figure 0004454988
Figure 0004454988

(結果)
液体の脂肪酸トリグリセリドを用いると、何も加えなかったときよりもAITの濃度は1000ppm以上低くなっており、また固体の脂肪酸トリグリセリドを用いるよりもさらに低くなっていた。このようにAITの濃度が低く抑えられていることから、揮散を抑制する効果が十分に現れていることがわかった。また、ロジンエステルを用いたときのような臭いや色の変化も無く、安定していた。
(result)
When liquid fatty acid triglycerides were used, the AIT concentration was 1000 ppm or more lower than when nothing was added, and even lower than when solid fatty acid triglycerides were used. Thus, since the density | concentration of AIT was suppressed low, it turned out that the effect which suppresses volatilization fully appears. Moreover, there was no change in odor and color as in the case of using rosin ester, and it was stable.

〔揮散性薬剤と脂肪酸トリグリセリドの混合比率の比較〕
50ml抽出ビン(マルエム社製)にリモネン(小川香料(株)製)2.0gと、所定の量の脂肪酸トリグリセリド(上記に同じ)と石油ワックス(上記に同じ)2.0gを入れて密閉し、85℃で加熱混練して相溶させた後、不織布にポリエチレンラミネートした厚み60μmの積層体からなる容器に充填した。この充填後の容器を密閉性のあるアルミ袋に入れて40℃の環境で1ヶ月放置した。1ヶ月後、容器表面の結露の状態を観察した。
また、上記の充填後の容器を25℃の環境に放置し、1ヶ月間に渡って、経時的にリモネンの臭いの有無を嗅覚によって確認し、揮散の安定性を調べた。なお、リモネンの香りが感じられるものを○、感じられないものを×と表記する。
[Comparison of mixing ratio of volatile drug and fatty acid triglyceride]
In a 50 ml extraction bottle (manufactured by Marem Co., Ltd.), 2.0 g of limonene (manufactured by Ogawa Fragrance Co., Ltd.), a predetermined amount of fatty acid triglyceride (same as above) and 2.0 g of petroleum wax (same as above) are sealed. The mixture was heat-kneaded at 85 ° C. and dissolved, and then filled into a container made of a laminate having a thickness of 60 μm laminated to a nonwoven fabric with polyethylene. The container after filling was put in an airtight aluminum bag and left in a 40 ° C. environment for one month. One month later, the state of condensation on the container surface was observed.
Further, the container after filling was left in an environment at 25 ° C., and over the course of one month, the presence or absence of the smell of limonene was confirmed over time, and the stability of volatilization was examined. In addition, the thing in which the scent of limonene is felt is described as “◯”, and the object in which the scent is not felt is denoted as “X”.

(実験例5〜8)
それぞれ、脂肪酸トリグリセリドの量を0.1g、0.5g、10.0g、25.0gとし、混練物の調製時におけるリモネンに対する重量比率がそれぞれ0.05倍、0.25倍、5.0倍、12.5倍となる条件で結露の状態と揮散の安定性を調べた。それぞれを実験例5〜8とし、それらの結果を表3に示す。
(Experimental Examples 5-8)
The amount of fatty acid triglyceride was 0.1 g, 0.5 g, 10.0 g, 25.0 g, respectively, and the weight ratios with respect to limonene at the time of preparing the kneaded product were 0.05 times, 0.25 times, 5.0 times, respectively. The state of condensation and the stability of volatilization were examined under the condition of 12.5 times. Each was made into Experimental Examples 5-8, and those results are shown in Table 3.

(比較例8)
脂肪酸トリグリセリドを添加することなく、結露の状態と揮散の安定性を調べた。その結果を表3に示す。
(Comparative Example 8)
The state of condensation and the stability of volatilization were investigated without adding fatty acid triglycerides. The results are shown in Table 3.

Figure 0004454988
Figure 0004454988

(結果)
実験例5では結露が見られたものの、10日間の揮散を続けることができた。実験例6及び7では、結露もなく、30日以上の揮散を続けることができた。実験例8では、5日間の揮散を続けることができた。一方、比較例8では結露が見られ、5日後には揮散が終わっていた。
(result)
In Experimental Example 5, dew condensation was observed, but the volatilization for 10 days could be continued. In Experimental Examples 6 and 7, there was no condensation and the volatilization continued for 30 days or more. In Experimental Example 8, the volatilization for 5 days could be continued. On the other hand, dew condensation was observed in Comparative Example 8, and volatilization was finished after 5 days.

Claims (4)

揮散性薬剤と、下記化学式(1)で示される常温で液状の脂肪酸トリグリセリドと、常温で固体の石油ワックスとを混練して、混練物を作成し、この混練物を液体不透過性の容器に充填した徐放性製剤。
Figure 0004454988
A volatile chemical, a fatty acid triglyceride that is liquid at normal temperature represented by the following chemical formula (1), and petroleum wax that is solid at normal temperature are kneaded to create a kneaded product, and the kneaded product is placed in a liquid-impermeable container. Filled sustained release formulation.
Figure 0004454988
上記混練物が、常温でペースト状または固形状である、請求項1に記載の徐放性製剤。   The sustained-release preparation according to claim 1, wherein the kneaded product is in a paste form or a solid form at room temperature. 上記混練物の調製時において、上記脂肪酸トリグリセリドの混合重量比率が、上記揮散性薬剤に対して、0.1〜10倍である請求項1又は2に記載の徐放性製剤。   The sustained-release preparation according to claim 1 or 2, wherein the mixing weight ratio of the fatty acid triglyceride is 0.1 to 10 times that of the volatile drug at the time of preparing the kneaded product. 上記揮散性薬剤がイソチオシアン酸アリルである、請求項1乃至のいずれかに記載の徐放性製剤。 The sustained-release preparation according to any one of claims 1 to 3 , wherein the volatile drug is allyl isothiocyanate.
JP2003306897A 2003-08-29 2003-08-29 Sustained release formulation Expired - Fee Related JP4454988B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003306897A JP4454988B2 (en) 2003-08-29 2003-08-29 Sustained release formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003306897A JP4454988B2 (en) 2003-08-29 2003-08-29 Sustained release formulation

Publications (2)

Publication Number Publication Date
JP2005075762A JP2005075762A (en) 2005-03-24
JP4454988B2 true JP4454988B2 (en) 2010-04-21

Family

ID=34409853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003306897A Expired - Fee Related JP4454988B2 (en) 2003-08-29 2003-08-29 Sustained release formulation

Country Status (1)

Country Link
JP (1) JP4454988B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006169189A (en) * 2004-12-17 2006-06-29 Rengo Co Ltd Chalkbrood disease-controlling agent
JP5710281B2 (en) * 2011-01-12 2015-04-30 花王株式会社 Solid lipid emulsion and topical skin preparation
JP6215418B2 (en) * 2015-08-31 2017-10-18 アース製薬株式会社 Drainage remover for drain

Also Published As

Publication number Publication date
JP2005075762A (en) 2005-03-24

Similar Documents

Publication Publication Date Title
JP6466551B2 (en) Aqueous gel bead type flying insect repellent
KR101774896B1 (en) Flying insect pest repellent product and method for repelling flying insect pest
JP4829589B2 (en) Flying pest repellent
JP6372774B2 (en) Insect repellent
JP4454988B2 (en) Sustained release formulation
JP2006296351A (en) Insect-proof agent
JP4829558B2 (en) Insect repellent
JP5858663B2 (en) Aromatic insect repellent
JP2019116450A (en) Flying pest repellent composition, and flying pest repellent blended with the same
JP2003246701A (en) Gelled insect repellent
JP5977073B2 (en) Flying insect repellent product using flying insect pest repellent composition
JP2010090048A (en) Drug vaporizer
JP2007153774A (en) Insect-proofing agent
JP2000281505A (en) Volatilizable packaging
JP2004254550A (en) Agent storage
JP5596532B2 (en) Flying insect repellent, flying insect repellent, and flying insect repellent method
TW202033093A (en) Clothes insect pest control composition, and clothes deodorizing method and clothes insect pest controlling and deodorizing method using said composition
JP7513518B2 (en) Indoor mite repellent and indoor mite repellent method
JP2004099568A (en) Gelatinous insecticide
JP6378047B2 (en) Insecticide for clothing
JP2006182817A (en) Resin composition for slow dissolution of chemical and liquid composition containing the resin composition
WO2020179617A1 (en) One-liquid-type aqueous aerosol composition
JP2005126393A (en) Aroma-releasing and insect-proofing product
JPWO2017077946A1 (en) Inverted volatilization device
JP2000175998A (en) Functional material including indicator function

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060615

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091113

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091210

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100112

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100203

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130212

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4454988

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130212

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130212

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130212

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees